ClinicalTrials.govpublic full text
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor
nsclc patients with egfr activating mutation, adenoid cystic carcinoma metastatic, adenoid cystic carcinoma of the head and neck, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 876970
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.